News and Trends 12 Dec 2022
Step Pharma announces promising pre-clinical cancer data
Step Pharma has announced encouraging pre-clinical data on its first-in-class, highly selective, orally bioavailable CTPS1 inhibitor, STP938. The data were presented at the 64th American Society of Hematology (ASH) annual…
